Xeris Pharmaceuticals, Inc.
Date of Award
02.19.2014
Program
Type 1 Diabetes, Improve Outcomes
Amount
$421,600
Term of Grant
25 months
Project Title
Rapid Acting Insulin and Insulin-Pramlintide Formulations for Treatment of Diabetes
02.19.2014
Type 1 Diabetes, Improve Outcomes
$421,600
25 months
Rapid Acting Insulin and Insulin-Pramlintide Formulations for Treatment of Diabetes